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When the interaction of complement components takes place, as, for example, 
upon  addition  of  an  antigen-antibody  complex  to  fresh  serum,  a  factor  is 
generated that is  chemotacfic for polymorphonuclear leukocytes (1,  2).  The 
factor has been characterized as a  trimolecular complex consisting of the fifth 
(C'5), sixth (C'6), and seventh (C'7) components of complement (2, 3). 
Recently it has been reported that when rabbit serum is treated with human 
plasmin,  a  chemotactic factor also appears  (4).  This paper now records the 
characterization of  this  new  chemotactic factor as  a  fragment  of  the  third 
component of complement (CP3, ~lC-globulin). As such,  this newly described 
chemotactic factor of low molecular weight is  completely different from the 
previously described  complement-associated  chemotactic factor,  in  terms  of 
requirements for generation as well as in physical-chemical characteristics. 
That C'3 is involved in the generation of this new chemotactic factor is of 
interest in view of the other known functions of C'3. These include its central 
role in immune adherence (5), immune phagocytosis (5, 6), and conglutination 
(7). Of particular interest are the reports by Dias da Silva and Lepow (8) that 
a fragment of C'3 is biologically active in causing contraction of smooth muscle, 
and by Miiller-Eberhard that a  factor in cobra venom when added to serum 
can cause  cleavage of C'3.1  The appearance of cleavage products of C'3,  at 
least one of which has biologic activity, has an obvious parallel in the present 
report. 
Materials and Methods  2 
Reagents.--Streptokinase (Sk) and highly purified human plasminogen (Plm), prepared as 
recently described (9), were supplied by Dr. Fletcher B. Taylor, Jr. (University of Pennsyl- 
* Supported by a grant from the United States Public Health Service,  National Institutes 
of Health Grant No. AI 07291-01 AIA. 
x Mttller-Eberhard, H. J. Isolation from cobra venom of an inactivator of the third com- 
ponent of complement  and its mode of action. Manuscript in preparation. 
The "Principles of Laboratory Animal Care" as promulgated by the National Society  for 
Medical Research were observed  during this study. 
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vania School of Medicine). The highly purified C'3 was supplied by Dr. Hans J. Miiller-Eber- 
hard  (Scripps Clinic and Research Foundation, La Jolla, Calif.). In some experiments,  C'3 
labeled with 131I was used as a convenient marker in preparatory and analytical procedures. 
Incubation of complement components with Sk-Plm was carried out in a  phosphate  buffer, 
pH 7.5, ionic strength 0.2, at 37°C for 2 hr. 
Chemotaxis.--Chambers were used that were separated into upper and lower compartments 
by a  micropore filter. These chambers, which are modifications of Boyden's originally de- 
scribed model (1), were employed in all chemotaxis experiments.  Details of these chambers 
and the technique for measuring chemotaxis have been presented in recent reports (2, 3). The 
system operates on the principle that a chemotactic substance in the lower compartment of a 
chamber can cause rabbit polymorphonuclear leukocytes (PMN's) to move in a specific and 
directional manner toward the increasing gradient of concentration of chemotactic factor. By 
the use of micropore filters, the migration of cells in the filter can be visualized and quantitated. 
Activation of Rabbit Serum.--In experiments in which the chemotactic factor in serum was 
used, the factor was generated by the addition of rabbit antibody to bovine serum albumin 
(anti-BSA) with antigen added at equivalence. 100 gg N anti-BSA, purified as IgG by elution 
from an ion exchange cellulose (10), was used for each milliliter of serum and incubated for 2 
hr at 37°C. The precipitate was then removed by centrifngation. 
Ele~trophoresis.--Preparative electrophoresis was carried  out in the  supporting  medium 
Pevikon with barbital buffer, pH 8.6, ionic strength 0.04. Duration of electrophoretic separa- 
tion of starting material was 18 hr. 
Ultracentrifugatlon.--Ultracentrifugal separation of various substances was attained by use 
of a sucrose density gradient (10-40% sucrose in phosphate buffer, pH 7.3, ionic strength 0.02) 
in a Beckman (Spinco)  model L ultracentrifuge. Depending on the rotor employed (SW-39 or 
SW-50),  the duration of centrifngation at 35,000, 40,000, or 50,000 rpm varied from 12 to 19 
hr. In one experiment, the density gradient was made up in 0.15 ~ sodium chloride in acetate 
buffer (0.01 M) at a pH of 5.0. Details of these procedures are found elsewhere (2). 
Column Chrornatography.--Ion exchange chromatography was employed for the isolation 
of the chemotactic factor of complement that consists of a  trimolecular complex of the fifth 
(C'5), sixth  (C'6), and seventh (C'7) components of complement (2, 3). This material was 
obtained by eluting rabbit englobulin from triethylaminoethyl cellulose (TEAE) with a  salt 
gradient. The resulting material  ("TEAE fraction") was then interacted with the first four 
reacting components of complement to activate the C'5, C'6, C'7 trimolecular complex to a 
chemotactically active substance. This procedure is described in detail in a prior report (2). 
Chromatography  utilizing a  gel filter  ("molecular sieve") was carried  out in  Sephadex 
G-50 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) with 0.15  ~  sodium chloride in 
acetate buffer at a pH of 5.0. The gel column was calibrated with blue dextran (Pharmacia), 
glucagon (Eli Lilly and Co., Indianapolis, Ind.), protamine sulfate (Sigma Chemical Corp., 
St. Louis, Mo.), and cytochrome c  (Mann Research Laboratories, Inc., New York, N. Y.) 
in order to obtain an elution sequence that could be plotted according to molecular weights 
(11).  When the treated C'3 preparation was eluted, the column was calibrated immediately 
before and afterwards with the known compounds. The resultant elution positions for each 
compound were found to be in excellent agreement, not varying by more than 1.0 ml. 
Immunodeclrophoresis.--An LKB-Produkter  (Stockholm, Sweden)  immunoelectrophoretic 
apparatus was used with a barbital buffer (pH 8.2, ionic strength 0.04).  Antibodies produced 
in rabbits or guinea pigs to human and rabbit C'3, respectively, were obtained by the method 
described recently by Mardiney and Mtiller-Eberhard (12). These preparations were utilized 
in immunoelectrophoretic and Ouchterlony double-diffusion  systems to assess changes in C'3 
and also  to detect C'3-related antigenic material in preparative electrophoretic fractions. PETER  A.  WARD  191 
RESULTS 
Comparison  of  Complement-Associated  Chemotactic Factor  and  Plasmin- 
Generated Chemotactic Factor.--A striking difference in the behavior of the two 
chemotactic factors  in  sucrose  density gradients  was  demonstrated.  When 
fresh rabbit serum that had been treated with an immune precipitate to activate 
the C15, Ct6, C'7 complex was analyzed, the chemotactically active fractions, 
although activity was low, were fouvd in the region of C'6 (Fig. 1, upper frame). 
On the other hand, fresh rabbit serum treated with Sk and Plm for 15 or 90 
rain acquired chemotactic activity that was confined to fractions from the top 
portion of the sucrose gradient (Fig.  1,  middle and lower frames). Both the 
C'6 and the protein profiles were shifted toward the top of the gradient as the 
duration of incubation with the Sk-Plm mixture increased from 15 to 90 rain. 
Because of the possibility that C'3 or C'5 (but not C'6)  a was involved in the 
appearance of the plasmin-generated chemotactic factor, TEAE fractions rich 
in these components were treated with Sk-Plm and analyzed in sucrose density 
gradient. When the untreated TEAE fraction was incubated with Sk and Plm 
at 37°C for 2 hr, chemotactic activity was sharply confined to the upper portion 
of the gradient (Fig. 2, upper frame, fraction 19). The protein in this gradient 
was distributed over a  wide zone, although a  peak was found in  the upper 
portion of the gradient (Fig. 2, upper frame). Very little hemolytic activity of 
C'6 remained. When the TEAE fraction was "activated" by interaction with 
the first four reacting components of complement in order to generate the com- 
plement-associated chemotactic factor, and  then  treated with Sk-Plm,  litde 
chemotactic activity remained  (a  chemotactic value  of 58  vs.  185  for  the 
material before  treatment).  Of  the little  C'6  activity remaining,  a  discrete 
biphasic distribution  with areas of rapidly and slowly sedimenting C'6  was 
observed  (Fig.  2,  middle  frame). When  the TEAE  fraction  that had been 
"activated" to  generate  the  complement-associated chemotactic factor  was 
analyzed in  the  gradient but was not subjected  to  treatment with Sk-Plm, 
chemotactic activity was confined, as expected,  to the area occupied by the 
more rapidly sedimenting C'6 fraction (Fig. 2, lower frame). These results re- 
vealed the striking difference in the velocity of sedimentation of the plasmin- 
generated  and  the  complement-associated chemotactic factors.  In addition, 
dissociation of the C'5, C'6,  C'7 complex and loss of C'6 hemolytic acitivity 
as a result of treatment with Sk-Plm was noted. 
Electrophoretic Changes in Rabbit  C'3 after  Treatment  with Sk-Plm.--When 
the TEAE fraction containing approximately 35  mg total protein,  which is 
rich in rabbit C'3, was incubated for 2 hr at 37°C with 10 mg Sk and 4 mg Plm, 
Sin a previous paper (4), C'6 was shown not to be required inasmuch as rabbit serum 
genetically  deficient  in C'6 supported  generation  of the chemotactic  factor. 192  A  NEW  CHEMOTACTIC  FACTOR  FROM  CI3 
FIG.  1.  Analysis of sucrose density gradient of rabbit serum (NRS) treated with strepto- 
kinase (Sk) and plasminogen (Plm). Activated serum has been incubated with immune com- 
plexes. (See text.) PETER  A,  WARD  193 
FIG. 2.  Comparison of complement-associated  and plasmin-generated chemotactic factors 
in sucrose density gradient ultracentrifugation. The plasmin-generated factor is slowly sedi- 
menting (upper frame), whereas the complement-associated  factor sediments relatively rap- 
idly (lower  frame). 
a definite change in the C'3 was noted. An antigenically different, fast-migrating 
band  appeared in  the  anodal  region  (Fig.  3).  The  main  C'3 band  was more 
intense and extended beyond the take-off point of the anodal band. This finding 
indicated the presence of antigenic material from the main C'3 molecule, which 
migrates electrophoretically more rapidly than the parent molecule. 
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TEAE Fraction.--Using  the same material examined in immunoelectrophoresis 
(described  above),  electrophoretic fractionation was  carried  out  at  a  pH  of 
8.6. No chemotactic activity was noted in fractions containing C~3 and the main 
protein peak (Fig. 4. fractions 6-9), but substantial chemotactic activity was 
contained in anodal fractions 10-14, a region that possessed antigenic material 
of  C'3.  In  Ouchterlony studies  not picture here,  the  anodal fractions  11-13 
contained C'3  antigenic material  that was  antigenically deficient when  corn- 
Fro. 3. Immunoelectrophoretic  analysis for rabbit C'3 in TEAE fraction before (left) and 
after (right) treatment with Sk-Plm. Anode  is at top. 
pared with fractions 8-% In TEAE fractions not treated with Sk-PIm, no such 
fast-migrating  zone with antigenic material  of C~3  was found; all of the  C'3 
remained with the main protein peak. 
Electrophoretic fractions 8,  10,  and  12  were  examined  in  sucrose density 
gradient to determine the relative sedimentation velocity of the chemotactic 
activity (Fig. 5).  Fraction 8,  chemotactically inactive, possessed protein with 
a  relatively rapid rate of sedimentation (upper frame), whereas both fractions 
10  and  12  contained protein and  chemotactic activity with a  relatively slow 
rate of sedimentation (middle and lower frames). In summary, these findings 
indicated  that  the  plasmin-generated  chemotactic factor was,  electrophorec- PETER A.  WARD  195 
tically, a  rapidly migrating material with a  slow velocity of sedimentation in 
the sucrose density gradient. There were also indications that this material was 
a split product of C'3. 
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FIG. 4.  E|ectrophorefic separation  of TEAE fraction  (rich in rabbit C'3, C'5, C'6, C'7) 
treated with Sk-Plm and analyzed for rabbit C'3 (/91C) and chemotactic activity. 
Plasmin Generation of Che'motactic A ctivity from Highly Purified Components 
of Human Complement.--Since the TEAE fraction is rich in C'3 and C'5, highly 
purified components of human complement were tested for ability to support 
generation of chemotactic activity after incubation with Sk-Plm. With C'3, 
substantial chemotactie activity could be generated when neither the purified, 196  A  NEW  CHEMOTACTIC  FACTOR  FROM  Ct3 
untreated  component nor the  Sk-Plm mixture  per  se possessed  chemotactic 
activity (Table I). In contrast, treatment of human C'5 with Sk-Plm failed  to 
result in the appearance of chemotactic activity. As anticipated, chemotactic 
0.I001 
o  o 
Z 
.J 
0 
U. 
J,s 
I-- 
0  tY 
a. 
I  FRACTION 8 
0.050 
0.100 
0.050 
0.100 
2  4  6  8  10  12  14  16 
ml 
II  FRACTION  10  ~]13 O0 
2  4  6  8  10  12  14  16  18  l  20  22 
lit  FRACTION 12 
200 
0.O5O 
100 
-.,._ 
2  4  6  8  10  12  14  16  18  20  22  24  26 
BOTTOM  FRACTION (TUBE NUMBER)  TOP 
FzG. 5. Analysis  in sucrose density gradient of electrophoretic  fractions described  in Fig. 4. 
activity could be generated by treatment of fresh human serum. These data, 
together with the finding that chemotacfic activity could be generated in rabbit 
serum genetically deficient in C'6, precluded the role of C'5 and C'6 in genera- 
tion of the factor and indicated a requirement for C'3 in the generation of this 
chemotactic factor. PETER  A. WARD  197 
Immunologic Investigations of Human C3 Treated with Sk-Plm.--In order to 
investigate  in  detail  the  plasmin-generated  chemotactic  factor,  6.88  mg  of 
highly purified human C'3, with 160 #g C'3-~3~I added as a tracer, was incubated 
with 5 mg Sk and 2.5 mg Plm at 37°C for 2 hr. Immunoelectrophoretic analysis 
of this  material  revealed  a  marked  change in  the  electrophoretic  mobility of 
C'3 after treatment (Fig. 6). Whereas the untreated material was demonstrable 
as  a  single  band  slightly  cathodal  to  the  point  of  origin  (left),  the  treated 
material  separated  into  three  discrete  bands  (right):  a  faint  residual  band 
similar  in  position  to  the  untreated  C'3,  a  main  band  of  electrophoretically 
"converted" faster migrating material, and a rapidly migrating anodal fraction 
that  was antigenically  deficient  when  compared with  the  intermediate  band. 
TABLE I 
Ability of Plasmin to Generate Chemotactic Activity .from Purified Components of 
Human Complement 
Material used  Amount  Sk-Plm*  Chemotactic value 
C'3 (fllC-globulin) 
C'5 (ElF-globulin) 
Human serum 
None 
32 #g 
65 pg 
65 #g 
133 #g 
40/zg 
40 #g 
100 #1 
100 #1 
Present 
Present 
Absent 
Present 
Present 
Absent 
Present 
Absent 
Present 
20 
98 
13 
130 
48 
58 
119 
15 
46 
* For each sample,  200 #g streptokinase  (SK) and 100 #g human plasminogen (100 #g) 
were added in a final volume of 200 ~zl, followed by incubation for 2 hr at 37°C, pH 7.5, in 
phosphate  buffer, ionic strength 0.2. 
Reduction in Sedimentation  Velocity of C'3 after  Treatment with Sk-Plm.--It 
was  shown  by  density  gradient  ultracentrifuged  analysis  that  treatment  of 
human  Ct3  with  Sk-Plm  resulted  in  a  reduction  in  sedimentation  velocity, 
implying a  reduction in molecular weight (Fig.  7).  It could be calculated  that 
the sedimentation  rate fell from a value for the untreated molecule of 9.5S  to 
9.0S.  It was also apparent  that with the  treated  C'3 a  discrete zone of radio- 
activity (which was not present  in the gradient containing the untreated  ma- 
terial) appeared in the upper regions of the gradient, implying cleavage products 
of  low  molecular  weight (See upper frame).  Approximately  10%  of the  total 
radioactivity appeared in this zone. When tests for chemotactic activity were 
carried  out  on various  fractions  of the  gradient,  activity was  rather  broadly 
distributed  over  the  upper  region  of  the  gradient  (also  upper  frame).  Little 
chemotactic activity was associated with  the main peak of radioactivity. 198  A  NEW  CHEMOTACTIC  FACTOR  FROM  CI3 
Electrophoretic  Separation  of  Plasmin-Generated  Chemotactic Factor from 
Human C3.--The  treated human  CP3 described above was electrophoretically 
fractionated in barbital buffer at a pH of 8.6. In a manner similar  to that used 
for the rabbit preparation  (Fig. 4),  the human  C'3 was separated  into a  main 
FIG. 6.  Immunoelectrophoretic  analysis  of human Ct3 before  (left) and after  treatment 
with Sk-Plm (right). Anode is at top. 
peak of radioactivity and a  minor, fast-moving peak,  the latter accounting for 
about 4 % of the total radioactivity (Fig. 8).  Chemotactic testing revealed that 
chemotactically active fractions were sharply confined to a  narrow region with 
rapidly migrating radioactive material  (See fractions 15 and 16). The presence 
of radioactivity in these fractions indicated the presence of some altered portion 
of Ct3,  since untreated  C/3  never gave such rapidly migrating material.  Frac- PE'I~R  A.  WARD  199 
tions 9 and 15 were tested both for the ability to enhance vascular permeability 
in the skin of the rat and to cause the accumulation of leukocytes in rat skin. 
In Table II it is shown that fraction 15 induced vascular permeability as well 
as  the  accumulation of polymorphonuclear leukocytes (PMN's)  in  the  rat, 
whereas fraction 9 possessed neither biologic activity. 
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Fzo. 7. Alteration in sedimentation pattern of C'3 (fllC-globulin) and location of chemo- 
tactic activity in density gradient fractions after treatment of C'3 with Sk-Plm. 
Characterization of  C'3 Fragments by Elution  fromSephadex G-50.--An mount 
of  Sk-Plm-treated  C'3  with a  radioactive marker  similar  to  that described 
above was eluted from a  Sephadex G-50 column with an acetate buffer at pH 
5.0. This Sephadex column was initially calibrated for the elufion profiles using 
cytochrome c, protamine,  and glucagon. Immediately thereafter the  treated 
C~3 was eluted. Mter this, and on the same day, the elufion positions of cyto- 
chrome c and protamine were again determined and were found to correspond 200  A  NEW  CH]~MOTACTIC FACTOR  FROM  Ct3 
within 0.7 ml to  the initial values for elution positions.  Fractions from the 
column containing C'3 were counted for radioactivity, neutralized, and tested 
for chemotactic activity. Radioactivity measurements indicated most of the 
material to be eluting in the void volume, followed by two discrete areas of 
radioactivity  (Fig. 9). The first of these two areas was eluted with approximately 
70 ml of buffer. The extrapolated molecular weight of this material was 12,000. 
The second, slightly biphasic peak, eluting in the position between 100 ml and 
115  ml,  contained material  with  an  estimated molecular  weight  of  6,000. 
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Fro. 8.  Electrophoretic separation of human C'3 (lower frame) after treatment with  Sk- 
Plm and localization of chemotactic activity (upper frame). 
Approximately 4 % of the radioactivity was contained in this zone. Chemotactic 
activity could be found only in the general area of this last zone of radioactivity 
(100 to 115 ml, Fig. 9).  From these findings it was apparent that treatment of 
human C'3 with Sk-Plm resulted in a fragment of low molecular weight split 
from CP3 that was chemotactically active for rabbit PMN's. 
DISCUSSION 
That plasmin can cause cleavage of C~3 to release a fragment chemotactieally 
active, both in chambers in vitro and in rat skin, indicates a property of plasmin PETER A.  WARD  201 
that has not been previously recorded. Although Ratnoff has recently reported 
the  ability of plasmin  to  cause increased vascular permeability, neither  the 
substrate nor the reaction product has been characterized (13). Nor is it clear 
from his data if accumulations of PMN's appeared after injection of plasmin 
into guinea  pig  skin.  The present  report may be  relevant to both  of  these 
questions. 
If  the  plasmin-split  fragment  of  C'3  is  important  in  the  mobilization  of 
PMN's in vivo, as the activated trimolecular complex of complement appears 
to  be  (3),  ~ a  second system for  the  regulation of PMN  function has  been 
defined. In animals  in which one of the complement components of the  tri- 
molecular complex is genetically absent (C'5 in the  mouse, reference 14,  C'6 
in the rabbit, reference 15), an alternative system for generating a chemotactic 
TABLE II 
Biologic Activities of th6 Plasmin-Split  Fragment of Human C'3 
Vascular permeability*  PMN accumulation  in rat skin~ 
(ram blueing) 
Rat 
Fraction 9  Fraction 15  Fraction 9  Fraction 15 
1  0  8  0  3+ 
2  3  8  4-  2+ 
3  0  3  0  2+ 
4  0  7  Not done  Not done 
* 0.5 ml of 1% Evans blue was injected intravenously, followed  immediately by 0.1 ml of 
each fraction intradermally. In all experiments, electrophoretic fraction 9 (see Fig. 8) was 
diluted 1:3 to achieve a protein concentration  comparable  to that of fraction 15. 
~5 Graded 0 to 4+ depending  upon intensity of PMN infiltration (see reference  13). 
factor would remain intact. Bemuse of the requirement for C'3 in both systems, 
it would be of great interest if a genetic deficiency of C'3 were found in animals 
or man~ in which case an additional chemotactic factor-generating system would 
be implied. 
In Table III the two chemotactic factors are compared in terms of the re- 
quirements for generation and according to their physical-chemical character- 
istics. To what extent each factor is important in biological reactions in which 
the mobilization of PMN's  occurs is not known. Under the usual conditions 
for activation of normal serum to produce the activated trimolecular complex, 
dialyzable chemotacitc activity is not found (2,  3, 4). No conclusions can be 
made about the situation as it applies in the intact animal. 
In view of the trypsin-like activity of plasmin,  the wide range of effects on 
the complement system is not surprising (16). In 1953, Pillemer and coworkers 
found that plasmin reduces the hemolytic activities of the second (C'2)  and 
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fourth (C'4)  components of complement and,  to a  lesser extent, activities of 
the first (C'I) and third (C'3) components (17). In 1958, Lepow, Ratnoff, and 
Levy described activation of the proesterase of C'1 by plasmin (18). The present 
report indicates  that  the  trimolecular complex (C'5,  C'6,  C'7)  is destroyed 
through dissociation of its subunits and reduction in hemolytic activity of C'6. 
The susceptibility of this complex to degradation by plasmin may account for 
the very short persistence of  the  trimolecular complex in  the  circulation of 
rabbits after its generation by the injection of zymosan (3). 
TABLE HI 
Comparison of Two Cheroot,  eric Factors* 
Property  Complement-associated  factor~:  Plasmin-generated  factor 
C'I-C'7  C'3  Requirement for 
generation 
Molecular weight 
Sedimentation velocity 
Antigenic composition 
Dialyzability 
Heat stability (56°C, 
1 hr) 
Electrophoretic 
mobility 
>300,000 
rapid 
fllF-globulin +  C'6 and C'7§ 
Does not pass through mem- 
brane 
stable 
intermediate 
6000 (approximate) 
slow 
/~lC-globulin fragment 
Passes through membrane 
labBe 
fast 
* This chart represents a compilation of data from this report as well as from references 
2, 3, and 4. 
Trimolecular complex  consisting of C'5, C'6, and C'7 (references  2 and 3). 
§ Antigens of C'6 and C'7 have not yet been characterized. 
Biologically active fragments of C'3 have recently been described that can 
apparently be differentiated from the plasmin-split fragment. Dias da Silva and 
Lepow report that anaphylatoxin is generated in free solution after interaction 
of the first four components of complement (8). The active material appears to 
be a fragment of C'3 that causes contraction of smooth muscle in guinea pig 
ileum and causes release of histamine from rat mast  cells. 5 Miiller-Eberhard 
has described the interaction of a  cobra venom factor and serum cofactor re- 
Dias da Silva, W., and W. Lepow. Personal communication. 204  A  NEW  CttEMOTACTIC  FACTOR  FROM  C~3 
suiting in a  complex that alters C'3  (19). In collaboration with Cochrane, he 
has found a  Cr3 fragment cleaved by the cobra venom factor-serum cofactor 
complex that causes the release of histamine from mast cells (20). In collabora- 
tion with Dias da Silva and Lepow, we have found that human anaphylatoxin 
lacks  chemotacfic activity.  8 Such a  finding is  not  surprising  in view of  the 
earlier report that the intermediate complex of the first four reacting compo- 
nents of human or guinea pig complement on sensitized erythrocytes was not 
chemotactic (2, 3). In contrast to the properties of human anaphylatoxin, the 
plasmin-split fragment of C'3 is chemotactic but does not cause contraction of 
guines pig ileum. ~,~ Further studies to define the structural and biologic proper- 
ties of these various C'3 fragments are indicated. 
SUMMARY 
When streptokinase and highly purified human plasminogen are added  to 
human serum or to partly purified or highly purified preparations containing 
the third component of complement (Ct3), either rabbit or human,  a chemo- 
tactic factor is generated. This chemotactic factor is a split product of C'3 and 
is dialyzable, fast  moving  electrophoretically, slowly  sedimenting  in  sucrose 
density gradient ultracentrifugation, and has an approximate molecular weight 
of 6000. It is calculated that this fragment accounts for approximately 4 % of 
the intact molecule. 
The C~3 fragment has the following biologic properties: It is chemotactic for 
rabbit PMN's in vitro, it causes accumulation of PMN's in vivo, and it increases 
vascular permeability in rat skin. 
In addition to generating a  chemotactic factor, plasmin destroys the  com- 
plement-associated chemotactic factor that is a trimolecular complex consisting 
of the fifth (C'5), sixth (C%), and seventh (C'7) components of complement. 
This has been shown by a loss of chemotactic activity, as well as a dissociation 
of the C'5, C'6, C'7 complex and a destruction of C'6 hemolytic activity. 
The biologic significance of the plasmin-generated chemotactic factor is dis- 
cussed  in  relation to  other recently discovered biologically active fragments 
of C'3. 
The author is indebted to Dr. Fletcher B. Taylor, Jr., University of Pennsylvania School 
of Medicine, who supplied the preparations of streptokinase and plasminogen. 
Part of the work reported in this paper was carried out in the laboratories of Dr. Hans J. 
Mtiller-Eberlmrd and Dr. Charles G. Cochrane of the Division of Experimental Pathology, 
Scripps Clinic and Research Foundation, La Jolla, Calif. The author is indebt~l  to Dr. 
M~ler-Eberhard for the availability of his laboratory facilities and the supply of highly 
purified preparations of human C'3 and C'5, and to Dr. Cochrane for his assistance in the 
laboratory procedures. 
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